Bernhard, Jürg

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2014 | 2012 | 2011 | 2010 | 2008 | 2007 | 2006 | 2004 | 2003

2014

Bourquin, Céline; Stiefel, Friedrich; Bernhard, Jürg; Bianchi Micheli, Gabriella; Dietrich, Liselotte; Hürny, Christoph; Wössmer, Brigitta; Kiss, Alexander (2014). Mandatory communication skills training for oncologists: enforcement does not substantially impact satisfaction. Supportive care in cancer, 22(10), pp. 2611-2614. Springer 10.1007/s00520-014-2240-1

Pagani, Olivia; Regan, Meredith M; Walley, Barbara A; Fleming, Gini F; Colleoni, Marco; Láng, István; Gomez, Henry L; Tondini, Carlo; Burstein, Harold J; Perez, Edith A; Ciruelos, Eva; Stearns, Vered; Bonnefoi, Hervé R; Martino, Silvana; Geyer, Charles E; Pinotti, Graziella; Puglisi, Fabio; Crivellari, Diana; Ruhstaller, Thomas; Winer, Eric P; ... (2014). Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. The New England journal of medicine, 371(2), pp. 107-118. Massachusetts Medical Society 10.1056/NEJMoa1404037

Bohlius, J; Tonia, T; Nüesch, E; Jüni, P; Fey, M F; Egger, M; Bernhard, J (2014). Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data. British journal of cancer, 111(1), pp. 33-45. Nature Publishing Group 10.1038/bjc.2014.171

Bernhard, Jürg; Dietrich, Daniel; Glimelius, Bengt; Bodoky, György; Scheithauer, Werner; Herrmann, Richard (2014). Clinical benefit response in pancreatic cancer trials revisited. Oncology research and treatment, 37(1-2), pp. 42-48. Karger 10.1159/000357965

2012

Pesce, Gianfranco A; Klingbiel, Dirk; Ribi, Karin; Zouhair, Abderahim; von Moos, Roger; Schlaeppi, Marc; Caspar, Clemens B; Fischer, Natalie; Anchisi, Sandro; Peters, Solange; Cathomas, Richard; Bernhard, Jürg; Kotrubczik, Nina M; D'Addario, Giannicola; Pilop, Christiane; Weber, Damien C; Bodis, Stephan; Pless, Miklos; Mayer, Michael and Stupp, Roger (2012). Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03). European journal of cancer, 48(3), pp. 377-84. Amsterdam: Elsevier 10.1016/j.ejca.2011.10.016

Ribi, K; Aldridge, J; Phillips, K-A; Thompson, A; Harvey, V; Thürlimann, B; Cardoso, F; Pagani, O; Coates, A S; Goldhirsch, A; Price, K N; Gelber, R D; Bernhard, J (2012). Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer. British journal of cancer, 106(10), pp. 1618-1625. Basingstoke: Nature Publishing Group 10.1038/bjc.2012.156

Brown, Richard; Butow, Phyllis; Wilson-Genderson, Maureen; Bernhard, Juerg; Ribi, Karin; Juraskova, Ilona (2012). Meeting the decision-making preferences of patients with breast cancer in oncology consultations: impact on decision-related outcomes. Journal of clinical oncology, 30(8), pp. 857-62. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2011.37.7952

Bernhard, Jürg; Butow, Phyllis; Aldridge, Julie; Juraskova, Ilona; Ribi, Karin; Brown, Richard (2012). Communication about standard treatment options and clinical trials: can we teach doctors new skills to improve patient outcomes? Psycho-oncology, 21(12), pp. 1265-1274. Malden, Mass.: Wiley-Blackwell 10.1002/pon.2044

2011

Phillips, Kelly-Anne; Aldridge, Julie; Ribi, Karin; Sun, Zhuoxin; Thompson, Alastair; Harvey, Vernon; Thürlimann, Beat; Cardoso, Fatima; Pagani, Olivia; Coates, Alan S; Goldhirsch, Aron; Price, Karen N; Gelber, Richard D; Bernhard, Jürg (2011). Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial. Breast cancer research and treatment, 126(1), pp. 221-6. Dordrecht: Springer 10.1007/s10549-010-1235-y

Brown, Richard F; Butow, Phyllis N; Juraskova, Ilona; Ribi, Karin; Gerber, Daniela; Bernhard, Jurg; Tattersall, Martin H N (2011). Sharing decisions in breast cancer care: Development of the Decision Analysis System for Oncology (DAS-O) to identify shared decision making during treatment consultations. Health expectations, 14(1), pp. 29-37. Oxford: Blackwell Publishing 10.1111/j.1369-7625.2010.00613.x

Smith, Allan; Juraskova, Ilona; Butow, Phyllis; Miguel, Caroline; Lopez, Anna-Lena; Chang, Sarah; Brown, Richard; Bernhard, Jurg (2011). Sharing vs. caring--the relative impact of sharing decisions versus managing emotions on patient outcomes. Patient education and counseling, 82(2), pp. 233-9. Shannon: Elsevier Ireland 10.1016/j.pec.2010.04.001

2010

Phillips, Kelly-Anne; Ribi, Karin; Sun, Zhuoxin; Stephens, Alisa; Thompson, Alastair; Harvey, Vernon; Thürlimann, Beat; Cardoso, Fatima; Pagani, Olivia; Coates, Alan S; Goldhirsch, Aron; Price, Karen N; Gelber, Richard D; Bernhard, Jürg (2010). Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial. Breast, 19(5), pp. 388-95. Amsterdam: Elsevier 10.1016/j.breast.2010.03.025

2008

Bernhard, J; Zahrieh, D; Zhang, J J; Martinelli, G; Basser, R; Hürny, C; Forbes, J F; Aebi, S; Yeo, W; Thürlimann, B; Green, M D; Colleoni, M; Gelber, R D; Castiglione-Gertsch, M; Price, K N; Goldhirsch, A; Coates, A S (2008). Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer. British journal of cancer, 98(1), pp. 25-33. Basingstoke: Nature Publishing Group 10.1038/sj.bjc.6604092

Wapnir, Irene L; Aebi, Stefan; Geyer, Charles E; Zahrieh, David; Gelber, Richard D; Anderson, Stewart J; Robidoux, André; Bernhard, Jürg; Maibach, Rudolf; Castiglione-Gertsch, Monica; Coates, Alan S; Piccart, Martine J; Clemons, Mark J; Costantino, Joseph P; Wolmark, Norman (2008). A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37. Clinical breast cancer, 8(3), pp. 287-92. New York, N.Y.: Elsevier 10.3816/CBC.2008.n.035

Ribi, Karin; Bernhard, Jürg; Schuller, Jan C; Weder, Walter; Bodis, Stephan; Jörger, Markus; Betticher, Daniel; Schmid, Ralph A; Stupp, Roger; Ris, Hans-Beat; Stahel, Rolf A (2008). Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes. Lung cancer, 61(3), pp. 398-404. Amsterdam: Elsevier 10.1016/j.lungcan.2008.01.013

Bernhard, Jürg; Dietrich, Daniel; Scheithauer, Werner; Gerber, Daniela; Bodoky, György; Ruhstaller, Thomas; Glimelius, Bengt; Bajetta, Emilio; Schüller, Johannes; Saletti, Piercarlo; Bauer, Jean; Figer, Arie; Pestalozzi, Bernhard C; Köhne, Claus-Henning; Mingrone, Walter; Stemmer, Salomon M; Tàmas, Karin; Kornek, Gabriela V; Koeberle, Dieter; Herrmann, Richard; ... (2008). Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001. Journal of clinical oncology, 26(22), pp. 3695-701. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2007.15.6240

2007

Bernhard, J; Zahrieh, D; Castiglione-Gertsch, M; Hürny, C; Gelber, RD; Forbes, JF; Murray, E; Collins, J; Aebi, S; Thürlimann, B; Price, KN; Goldhirsch, A; Coates, AS; International, Breast Cancer Study Group Trial VIII (2007). Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII. Journal of clinical oncology, 25(3), pp. 263-70. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.04.5393

Münger-Beyeler, C; Bernhard, J; Rufibach, K; Morant, R; Schmid, H-P (2007). Quality of analgesic treatment in patients with advanced prostate cancer: do we do a better job now? The Swiss Group for Clinical Cancer Research (SAKK) experience. Supportive care in cancer, 16(5), -. Berlin: Springer 10.1007/s00520-007-0335-7

Ribi, K; Bernhard, J; Rufibach, K; Thürlimann, B; von Moos, R; Ruhstaller, T; Glaus, A; Böhme, C (2007). Endocrine symptom assessment in women with breast cancer: what a simple "yes" means. Supportive care in cancer, 15(12), pp. 1349-56. Berlin: Springer 10.1007/s00520-007-0258-3

Weder, W; Stahel, RA; Bernhard, J; Bodis, S; Vogt, P; Ballabeni, P; Lardinois, D; Betticher, D; Schmid, R; Stupp, R; Ris, HB; Jermann, M; Mingrone, W; Roth, AD; Spiliopoulos, A; Swiss, Group for Clinical Cancer Research (2007). Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Annals of oncology, 18(7), pp. 1196-202. Oxford: Oxford University Press 10.1093/annonc/mdm093

Roth, AD; Fazio, N; Stupp, R; Falk, S; Bernhard, J; Saletti, P; Köberle, D; Borner, MM; Rufibach, K; Maibach, R; Wernli, M; Leslie, M; Glynne-Jones, R; Widmer, L; Seymour, M; de Braud, F; Swiss, Group for Clinical Cancer Research (2007). Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research. Journal of clinical oncology, 25(22), pp. 3217-23. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2006.08.0135

Herrmann, R; Bodoky, G; Ruhstaller, T; Glimelius, B; Bajetta, E; Schüller, J; Saletti, P; Bauer, J; Figer, A; Pestalozzi, B; Köhne, CH; Mingrone, W; Stemmer, SM; Tàmas, K; Kornek, GV; Koeberle, D; Cina, S; Bernhard, J; Dietrich, D; Scheithauer, W; ... (2007). Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group. Journal of clinical oncology, 25(16), pp. 2212-7. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2006.09.0886

Bernhard, Jürg (2007). Quality of life and quality-adjusted survival. British journal of cancer, pp. 40-50. Basingstoke: Nature Publishing Group

2006

Rudenstam, CM; Zahrieh, D; Forbes, JF; Crivellari, D; Holmberg, SB; Rey, P; Dent, D; Campbell, I; Bernhard, J; Price, KN; Castiglione-Gertsch, M; Goldhirsch, A; Gelber, RD; Coates, AS; International, Breast Cancer Study Group (2006). Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. Journal of clinical oncology, 24(3), pp. 337-44. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.01.5784

2004

Bernhard, Jürg; Lowy, Adam; Mathys, Natascha; Herrmann, Richard; Hürny, Christoph (2004). Health related quality of life: a changing construct? Quality of life research, 13(7), pp. 1187-97. Dordrecht: Springer 10.1023/B:QURE.0000037485.59681.7d

Sabbioni, Marzio E E; Bernhard, Jürg; Siegrist, Hans-Peter; Schmitz, Shu-Fang Hsu; Gertsch, Monica Castiglione; Thürlimann, Beat; Bonnefoi, Hervé; Perey, Lucien; Herrmann, Richard; Goldhirsch, Aron; Hürny, Christoph; Swiss Group for Clinical Cancer Research (SAKK), (2004). Does subjective burden of early breast cancer and its treatment affect immune measures during adjuvant therapy? Breast cancer research and treatment, 87(1), pp. 75-86. Dordrecht: Springer 10.1023/B:BREA.0000041584.53863.a7

2003

Phillips, Kelly-Anne; Bernhard, Jürg (2003). Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. Journal of the National Cancer Institute JNCI, 95(3), pp. 190-7. Cary, N.C.: Oxford University Press 10.1093/jnci/95.3.190

Schmid, Hans-Peter; Morant, Rudolf; Bernhard, Jürg; Maibach, Rudolf; Swiss Group for Clinical Cancer Research (SAKK), (2003). Prostate specific antigen doubling time as auxiliary end point in hormone refractory prostatic carcinoma. European urology, 43(1), pp. 28-30. Amsterdam: Elsevier 10.1016/S0302-2838(02)00539-0

Provide Feedback